Follow
Lorea Villanueva Legarda
Lorea Villanueva Legarda
Centro de Investigación Médica Aplicada/Universidad de Navarra
Verified email at alumni.unav.es
Title
Cited by
Cited by
Year
The contribution of epigenetics to cancer immunotherapy
L Villanueva, D Álvarez-Errico, M Esteller
Trends in immunology 41 (8), 676-691, 2020
1522020
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
D Llopiz, M Ruiz, L Villanueva, T Iglesias, L Silva, J Egea, JJ Lasarte, ...
Cancer Immunology, Immunotherapy 68, 379-393, 2019
1132019
Inhibition of FOXP3/NFAT interaction enhances T cell function after TCR stimulation
T Lozano, L Villanueva, M Durántez, M Gorraiz, M Ruiz, V Belsue, ...
The Journal of Immunology 195 (7), 3180-3189, 2015
552015
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
C Mansilla, P Berraondo, M Durantez, M Martínez, N Casares, ...
International Journal of Cancer 131 (3), 641-651, 2012
532012
IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination
D Llopiz, M Ruiz, S Infante, L Villanueva, L Silva, S Hervas-Stubbs, ...
Oncotarget 8 (2), 2659, 2017
422017
Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies
CA Garcia-Prieto, L Villanueva, A Bueno-Costa, V Davalos, ...
JNCI: Journal of the National Cancer Institute 114 (3), 436-445, 2022
322022
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
F Rudilla, C Fayolle, N Casares, M Durantez, L Arribillaga, T Lozano, ...
Vaccine 30 (18), 2848-2858, 2012
272012
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
A Zabaleta, D D'avola, I Echeverria, D Llopiz, L Silva, L Villanueva, ...
Molecular therapy Methods & clinical development 2, 2015
232015
A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo
L Arribillaga, M Durantez, T Lozano, F Rudilla, F Rehberger, N Casares, ...
BioMed research international 2013, 2013
202013
Cold-inducible RNA binding protein as a vaccination platform to enhance immunotherapeutic responses against hepatocellular carcinoma
L Silva, J Egea, L Villanueva, M Ruiz, D Llopiz, D Reparaz, B Aparicio, ...
Cancers 12 (11), 3397, 2020
182020
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in first-line metastatic triple-negative breast cancer: A systematic review and meta-analysis
G Villacampa, P Tolosa, F Salvador, R Sánchez-Bayona, L Villanueva, ...
Cancer Treatment Reviews 104, 102352, 2022
172022
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
L Villanueva, L Silva, D Llopiz, M Ruiz, T Iglesias, T Lozano, N Casares, ...
Oncoimmunology 7 (4), e1409321, 2018
172018
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
JM Cejalvo, C Falato, L Villanueva, P Tolosa, X González, M Pascal, ...
Cancer Treatment Reviews 106, 102392, 2022
122022
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
L Arribillaga, I Echeverria, V Belsue, T Gomez, T Lozano, N Casares, ...
Journal for immunotherapy of cancer 8 (1), 2020
102020
DNA methylation-associated dysregulation of transfer RNA expression in human cancer
M Rosselló-Tortella, A Bueno-Costa, L Martínez-Verbo, L Villanueva, ...
Molecular Cancer 21 (1), 48, 2022
92022
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance
A Zabaleta, JI Riezu‐Boj, E Larrea, L Villanueva, JJ Lasarte, E Guruceaga, ...
Journal of medical virology 88 (5), 843-851, 2016
32016
The HDAC inhibitor belinostat enhances the anti-tumor efficacy of immune checkpoint inhibitors in a murine hepatocellular carcinoma model
D Llopiz, M Ruiz, L Villanueva, T Iglesias, JJ Lasarte, P Pivette, ...
Journal of Hepatology 68, S677, 2018
22018
Comorbilidad del trastorno hipercinético en la práctica clínica
P RodrigueZ-Ramos, R García-Pérez, FS Picazo, P Ortega, C Carrascosa, ...
Revista de Psiquiatría Infanto-Juvenil, 226-232, 1997
11997
Abstract P22: PVR (CD155) epigenetic status mediates adoptive cell therapy and anti-TIGIT response in Multiple Myeloma
L Martinez-Verbo, L Villanueva, P Llinàs-Arias, CA García-Prieto, ...
Blood Cancer Discovery 5 (2_Supplement), P22-P22, 2024
2024
CD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies
L Martinez-Verbo, L Villanueva, P Llinàs-Arias, CA García-Prieto, ...
Blood 142, 6567, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20